Tag Archives: Jon Saxe

A Director at VistaGen Therapeutics (NASDAQ: VTGN) is Buying Shares

Today, a Director at VistaGen Therapeutics (VTGN – Research Report), Jon Saxe, bought shares of VTGN for $25.16K. In addition to Jon Saxe, one other VTGN executive reported Buy trades in the last month. See today’s analyst top recommended stocks

A Director at VistaGen Therapeutics is Exercising Options

Today it was reported that a Director at VistaGen Therapeutics (VTGN – Research Report), Jon Saxe, exercised options to buy 1,375 VTGN shares at $1.50 a share, for a total transaction value of $2,062. The options were close to expired